Courtney DiNardo, MD- Innovative Combinations of IDH Inhibitors Acute Myelogenous Leukemia 1 Min Read5 Courtney DiNardo, MD- Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,…
Courtney DiNardo, MD,MSCE – Azacitidine,Venetoclax, IDH inhibitor Acute Myelogenous Leukemia 1 Min Read24 Courtney D. DiNardo, MD, MSCE Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson…
Case #3: New Possibilities for Maintenance Therapy in AML Acute Lymphoblastic Leukemia 1 Min Read0 A new maintenance option is available for AML, but are you proficient in identifying eligible patients? Dr. DiNardo and Dr.…
